Medical Doctor Program year 2022 Reported 2019–2022 Source: CMS Open Payments, 2026 publication

Edison Rodrigues

Gastroenterology Corpus Christi, TX Medical Doctor

NPI 1508864489 CMS profile 340751

718 Elizabeth St Fl 3, Corpus Christi, TX 78404

Open in the dashboard

General payments

$1,304

72 records reported · program years 2019–2022

Research payments

$0

Paid to them · None reported · program years 2019–2022

Ownership & investment interest

$0

None reported

Through program year 2022, Edison Rodrigues of Corpus Christi, TX is reported in the CMS Open Payments database as having received $1,304 across 72 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 39th percentile of Gastroenterology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2022 General $268 16
2021 General $432 24
2020 General $74 5
2019 General $531 27

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Edison Rodrigues
  • Gastroenterology median
  • Middle half of Gastroenterology
  • National median

In program year 2025, general payments to Edison Rodrigues were reported at $0. Among 13,050 Gastroenterology profiles paid that year, the median was $639 and the middle half received between $167 and $1,700.

Show as a table
Year Edison Rodrigues Gastroenterology median Middle half National median
2019 $531 $417 $126–$1,100 $163
2020 $74 $224 $74–$624 $114
2021 $432 $352 $106–$1,054 $132
2022 $268 $448 $129–$1,270 $149
2023 $0 $533 $150–$1,390 $160
2024 $0 $605 $160–$1,606 $164
2025 $0 $639 $167–$1,700 $169

Breakdown

Who paid General payments · program years 2019–2022
  1. Boston Scientific Corporation $385 24 payments
  2. AbbVie, Inc. $263 15 payments
  3. Gilead Sciences, Inc. $231 13 payments
  4. Salix Pharmaceuticals, a division of Bausch Health US, LLC $161 5 payments
  5. Olympus America Inc. $97 4 payments
  6. Intercept Pharmaceuticals, Inc. $85 6 payments
  7. Shionogi Inc $23 1 payment
  8. Ambu Inc. $20 1 payment
  9. Shire North American Group Inc $15 1 payment
  10. Celgene Corporation $15 1 payment
  11. Other $11 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2022
  1. Food and Beverage $1,304 72 payments
Products named General payments · program years 2019–2022
  1. EXALT $156 8 payments
  2. MAVYRET $109 6 payments
  3. CREON $100 6 payments
  4. EXALT Model D $96 6 payments
  5. TRULANCE Gastroenterology $92 1 payment
  6. OCALIVA $85 6 payments
  7. XIFAXAN $69 4 payments
  8. HUMIRA $54 3 payments
  9. VISIGLIDE $50 2 payments
  10. TRULANCE Gastroenterology $31 2 payments
  11. Other $234 17 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 25 billing codes

Paid by Medicare

$11,662

Medicare's payments for the services billed

Medicare patients

67

Average age 73

Services billed

113

45 women, 22 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 63%
Depression 45%
Ischemic heart disease 40%
Diabetes 37%
Chronic kidney disease 34%
COPD 33%
Atrial fibrillation 31%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

72 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Gastroenterology in Texas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2022

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record